Measles - Local update

Local health departments have not recommended additional vaccination beyond current guidelines. Texas health officials urge immunization to protect against and prevent the spread of measles. ARC has received additional vaccines for children and adults to keep the community protected. Read our measles vaccination guidelines.

Visit the DSHS website to track the current outbreak in Texas.

ARC in-network with UHC

If you have received a letter from UnitedHealthcare (UHC) stating that any of the providers listed below are out-of-network, please be informed that refers to their former practice. The following physicians and APC remain in-network at ARC, and you may continue seeing them without any changes to your coverage:

MyChart Login Help Me Book

Chronic Spontaneous Urticaria (USC) Clinical Study

Austin Regional Clinic physicians constantly work to improve the care given to all our patients. We are dedicated to offering unique options for our patients and helping them reach their ideal health goals. Part of this dedication involves making clinical research available. Clinical research makes it possible to discover the benefits, risks, and safety of commercially available and investigational medications.

Research standards are very strict to help make studies as safe as possible. Teams of government and research experts have already reviewed each study we conduct to minimize any study risks. Austin Regional Clinic has decided to be involved in this research study because we believe it can potentially benefit our patients.

About the chronic spontaneous urticaria study

This study is evaluating the efficacy and safety of EV0756 in people with moderate to severe CSU. CSU is a condition where people have hives and local skin swelling that can show up anywhere on the body and last for six weeks or longer. 

By participating in this study, you would be contributing to the development of groundbreaking technology with the potential to benefit many people in the future. ARC is one of the many study centers in the United States participating in this research study.

What to expect

During the study, patients can expect:

  • To take study medication twice a day
  • 12 weeks of treatment and a 2-week follow-up visit

Eligibility criteria

All participants must:

  • Be 18 and older
  • Be willing to complete diaries daily
  • Be able to comply with study requirements
  • Have chronic spontaneous urticaria for ≥ 3 months with an inadequate response to H1 antihistamines

Subjects taking H1 antihistamines must be on a stable regimen 4 weeks prior to day 1 and while participating in the study.

Location

Request to participate

Please contact our ARC Clinical Research team to request to participate by calling 737-247-7240.